首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1547713

全球數位治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Digital Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球數位治療市場需求預計將從 2023 年的 67.6 億美元達到 2032 年近 616 億美元的市場規模，2024-2052 年研究期間複合年成長率為 27.83%。

數位治療 (DTx) 是一種新的數位醫療保健概念，可為患者提供基於證據的治療干預措施。 DTx 由高品質軟體程式驅動，用於預防、管理或治療廣泛的身體、精神和行為狀況。數位療法增強並支持目前的醫學治療。它為患者、提供者和付款人提供了新穎的治療選擇，以滿足未滿足的醫療需求，並減少了對傳統醫療保健系統或其他療法的依賴。它可以單獨應用或與其他治療結合應用。

市場動態

預計全球數位治療市場在預測期內將以指數速度成長。數位化顛覆了所有產業，醫療保健也不例外。行動技術和人工智慧 (AI) 的進步擴大了數位療法在醫療保健中的作用。患者對數位療法的認知不斷增強，他們的健康狀況以及他們在疾病管理中發揮更積極作用的能力創造了潛在的健康結果並減少了傳統醫療保健系統的成本。主要參與者正在投資這個概念，並選擇與科技公司建立策略夥伴關係來開拓市場。透過合作取得的令人興奮的進步將創造市場機會。然而，世界某些地區缺乏認知正在阻礙市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球數位治療市場的每個細分市場進行了包容性評估。數位治療行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

數位治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按申請

糖尿病
肥胖
CVD
呼吸系統疾病
戒菸
中樞神經系統疾病
其他

按最終用途

患者
供應商
付款人
雇主
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲數位治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。數位治療市場的主要參與者包括 Omada Health Inc.、Welldoc Inc.、2Morrow Inc.、Teladoc Health Inc.、Propeller Health (ResMed)、Fitbit LLC、Canary Health、Noom Inc.、Pear Therapeutics Inc.、Akili Interactive Labs Inc.、Hygieia、DarioHealth Corp.、BigHealth、GAIA AG、Limbix Health Inc.、Mango Health。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：數位治療公司的競爭格局

數位治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Omada Health Inc.

公司概況
公司收入
產品
最新動態

Welldoc Inc.

公司概況
公司收入
產品
最新動態

2Morrow Inc

公司概況
公司收入
產品
最新動態

Teladoc Health Inc.

公司概況
公司收入
產品
最新動態

Propeller Health (ResMed)

公司概況
公司收入
產品
最新動態

Fitbit LLC

公司概況
公司收入
產品
最新動態

Canary Health

公司概況
公司收入
產品
最新動態

Noom Inc.

公司概況
公司收入
產品
最新動態

Pear Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Akili Interactive Labs Inc.

公司概況
公司收入
產品
最新動態

Hygieia

公司概況
公司收入
產品
最新動態

DarioHealth Corp.

公司概況
公司收入
產品
最新動態

BigHealth

公司概況
公司收入
產品
最新動態

GAIA AG

公司概況
公司收入
產品
最新動態

Limbix Health Inc.

公司概況
公司收入
產品
最新動態

Mango Health

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213684

The global demand for Digital Therapeutics Market is presumed to reach the market size of nearly USD 61.6 Billion by 2032 from USD 6.76 Billion in 2023 with a CAGR of 27.83% under the study period 2024-2052.

Digital therapeutics (DTx) is a new digital healthcare concept that delivers evidence-based therapeutic interventions to patients. DTx is driven by high-quality software programs to prevent, manage, or treat a broad spectrum of physical, mental, and behavioral conditions. Digital therapeutics enhance and support current medical treatments. It provides patients, providers, and payers with novel therapy options for unmet medical needs and reduces reliance on traditional healthcare system or other therapies. It can be applied independently or in conjunction with other treatments.

MARKET DYNAMICS

The global digital therapeutics market is forecast to grow at an exponential rate during the forecast period. Digitalization has disrupted all the sectors, and healthcare is not an exception. Advances in mobile technology and artificial intelligence (AI) have broadened the role of digital therapeutics in healthcare. Growing awareness about digital therapeutics among patients of their health and their ability to play a more active role in managing their disease create potential health outcomes and reduce traditional healthcare systems expenses. Key players are investing in the concept and opting for strategic partnerships with tech companies to explore the market. The exciting advancement through collaboration will create market opportunities. However, lack of awareness in some parts of the world is hampering the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Digital Therapeutics. The growth and trends of Digital Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Digital Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Diabetes
Obesity
CVD
Respiratory Diseases
Smoking Cessation
CNS Diseases
Others

By End-use

Patients
Providers
Payers
Employers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Digital Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Therapeutics market include Omada Health Inc., Welldoc Inc., 2Morrow Inc, Teladoc Health Inc., Propeller Health (ResMed), Fitbit LLC, Canary Health, Noom Inc., Pear Therapeutics Inc., Akili Interactive Labs Inc., Hygieia, DarioHealth Corp., BigHealth, GAIA AG, Limbix Health Inc., Mango Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. DIGITAL THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By End-use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data
5.3. Analysis By Application
5.4. Diabetes Historic and Forecast Sales By Regions
5.5. Obesity Historic and Forecast Sales By Regions
5.6. CVD Historic and Forecast Sales By Regions
5.7. Respiratory Diseases Historic and Forecast Sales By Regions
5.8. Smoking Cessation Historic and Forecast Sales By Regions
5.9. CNS Diseases Historic and Forecast Sales By Regions
5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS BY END-USE

6.1. Overview By End-use
6.2. Historical and Forecast Data
6.3. Analysis By End-use
6.4. Patients Historic and Forecast Sales By Regions
6.5. Providers Historic and Forecast Sales By Regions
6.6. Payers Historic and Forecast Sales By Regions
6.7. Employers Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE DIGITAL THERAPEUTICS COMPANIES

8.1. Digital Therapeutics Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF DIGITAL THERAPEUTICS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Omada Health Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Welldoc Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. 2Morrow Inc
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Teladoc Health Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Propeller Health (ResMed)
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Fitbit LLC
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Canary Health
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Noom Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Pear Therapeutics Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Akili Interactive Labs Inc.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Hygieia
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. DarioHealth Corp.
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. BigHealth
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. GAIA AG
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Limbix Health Inc.
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Mango Health
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments